Financial Statements · From SEC 10-K & 10-Q XBRL Filings
UnitedHealth Group Incorporated Revenue & Financial Statements
UnitedHealth Group Incorporated reported revenue of $447.6B for the fiscal year ended December 31, 2025, up 11.8% year over year, with net income of $12.8B and diluted EPS of $13.23.
- Company
- UnitedHealth Group Incorporated UNH · NYSE
- Latest fiscal year
- FY ended Dec 31, 2025
- Statements
- Income · Balance Sheet · Cash Flow — 5 fiscal years, 8 quarters
Income Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 287.6B | 324.2B | 371.6B | 400.3B | 447.6B |
| Cost of revenue | 31.0B | 33.7B | 38.8B | 46.7B | 50.7B |
| Gross profit | 256.6B | 290.5B | 332.9B | 353.6B | 396.9B |
| Operating income | 24.0B | 28.4B | 32.4B | 32.3B | 19.0B |
| Pretax income | 22.3B | 26.3B | 29.1B | 28.3B | (196.0M) |
| Net income | 17.3B | 20.1B | 22.4B | 14.4B | 12.8B |
| Diluted EPS | 18.08 | 21.18 | 23.86 | 15.51 | 13.23 |
| EBITDA | 25.0B | 29.5B | 33.5B | 33.3B | 23.3B |
Quarterly
| USD | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 99.8B | 98.9B | 100.8B | 100.8B | 109.6B | 111.6B | 113.2B | 113.2B |
| Cost of revenue | 11.1B | 11.3B | 11.8B | 12.5B | 12.4B | 13.0B | 12.6B | 12.7B |
| Gross profit | 88.7B | 87.5B | 89.0B | 88.3B | 97.2B | 98.6B | 100.6B | 100.5B |
| Operating income | 7.9B | 7.9B | 8.7B | 7.8B | 9.1B | 5.2B | 4.3B | 380.0M |
| Pretax income | 1.0M | 5.7B | 7.6B | 6.8B | 8.1B | 4.1B | 3.2B | (720.0M) |
| Net income | (1.4B) | 4.2B | 6.1B | 5.5B | 6.3B | 3.4B | 2.3B | 218.0M |
| Diluted EPS | -1.53 | 4.54 | 6.51 | 5.98 | 6.85 | 3.74 | 2.59 | 0.02 |
| EBITDA | 8.9B | 8.9B | 9.7B | 8.8B | 10.2B | 6.2B | 5.4B | 1.5B |
Balance Sheet
Fiscal year-end snapshots. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 212.2B | 245.7B | 273.7B | 298.3B | 309.6B |
| Current assets | 61.8B | 69.1B | 78.4B | 85.8B | 90.6B |
| Cash & equivalents | 21.4B | 23.4B | 25.4B | 25.3B | 24.4B |
| Total liabilities | 135.7B | 159.4B | 174.8B | 195.7B | 207.9B |
| Current liabilities | 78.3B | 89.2B | 99.1B | 103.8B | 114.9B |
| Long-term debt | 42.4B | 54.5B | 58.3B | 72.4B | 72.3B |
| Total debt | 46.0B | 54.5B | 58.3B | 72.4B | 72.3B |
| Stockholders’ equity | — | — | — | — | — |
| Net debt | 24.6B | 31.1B | 32.8B | 47.0B | 48.0B |
Cash Flow Statement
Annual, as reported in 10-K filings. Values in USD.
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | 22.3B | 26.2B | 29.1B | 24.2B | 19.7B |
| Investing cash flow | (10.4B) | (28.5B) | (15.6B) | (20.5B) | (8.7B) |
| Financing cash flow | (7.5B) | 4.2B | (11.5B) | (3.5B) | (11.6B) |
| Capital expenditure | 2.5B | 2.8B | 3.4B | 3.5B | 3.6B |
| Free cash flow | 19.9B | 23.4B | 25.7B | 20.7B | 16.1B |
| Dividends paid | — | — | — | — | — |
| Stock-based compensation | 800.0M | 925.0M | 1.1B | 1.0B | 971.0M |
Figures are parsed from SEC XBRL company facts and may be derived where issuers report year-to-date values (quarterly figures differenced; Q4 computed as FY minus Q3). Fiscal periods follow each company's fiscal calendar, not calendar years. Historical fact, not investment advice — verify with official SEC filings.
Every UNH filing, connected
Financials beside price, insider trades, and 8-K events — with alerts the moment something new is filed.